nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—Cytochrome P450 3A4 Inhibitors—Amprenavir—acquired immunodeficiency syndrome	0.245	0.412	CiPCiCtD
Boceprevir—Cytochrome P450 3A4 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.175	0.294	CiPCiCtD
Boceprevir—Cytochrome P450 3A4 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.175	0.294	CiPCiCtD
Boceprevir—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0182	0.0775	CbGbCtD
Boceprevir—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0165	0.0701	CbGbCtD
Boceprevir—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0165	0.0701	CbGbCtD
Boceprevir—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0142	0.0605	CbGbCtD
Boceprevir—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0138	0.0588	CbGbCtD
Boceprevir—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0125	0.0531	CbGbCtD
Boceprevir—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0125	0.0531	CbGbCtD
Boceprevir—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0119	0.0505	CbGbCtD
Boceprevir—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0107	0.0456	CbGbCtD
Boceprevir—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00927	0.0394	CbGbCtD
Boceprevir—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.009	0.0382	CbGbCtD
Boceprevir—CMA1—Metabolism of Angiotensinogen to Angiotensins—ENPEP—acquired immunodeficiency syndrome	0.00837	0.311	CbGpPWpGaD
Boceprevir—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00814	0.0346	CbGbCtD
Boceprevir—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00814	0.0346	CbGbCtD
Boceprevir—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0078	0.0332	CbGbCtD
Boceprevir—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00757	0.0322	CbGbCtD
Boceprevir—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00711	0.0302	CbGbCtD
Boceprevir—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00711	0.0302	CbGbCtD
Boceprevir—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00643	0.0273	CbGbCtD
Boceprevir—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00643	0.0273	CbGbCtD
Boceprevir—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00603	0.0256	CbGbCtD
Boceprevir—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00555	0.0236	CbGbCtD
Boceprevir—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00539	0.0229	CbGbCtD
Boceprevir—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00488	0.0207	CbGbCtD
Boceprevir—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00488	0.0207	CbGbCtD
Boceprevir—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00467	0.0199	CbGbCtD
Boceprevir—CMA1—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.0022	0.0819	CbGpPWpGaD
Boceprevir—CTSV—Endosomal/Vacuolar pathway—HLA-B—acquired immunodeficiency syndrome	0.00211	0.0786	CbGpPWpGaD
Boceprevir—CTSL—Endosomal/Vacuolar pathway—HLA-B—acquired immunodeficiency syndrome	0.00211	0.0786	CbGpPWpGaD
Boceprevir—CTSS—Endosomal/Vacuolar pathway—HLA-B—acquired immunodeficiency syndrome	0.00144	0.0536	CbGpPWpGaD
Boceprevir—CTSV—skin of body—acquired immunodeficiency syndrome	0.00121	0.0314	CbGeAlD
Boceprevir—CMA1—skin of body—acquired immunodeficiency syndrome	0.00116	0.03	CbGeAlD
Boceprevir—CTSL—retina—acquired immunodeficiency syndrome	0.00113	0.0292	CbGeAlD
Boceprevir—Telaprevir—ALB—acquired immunodeficiency syndrome	0.0011	1	CrCbGaD
Boceprevir—CTSL—skin of body—acquired immunodeficiency syndrome	0.000991	0.0256	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—acquired immunodeficiency syndrome	0.000983	0.0254	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—acquired immunodeficiency syndrome	0.000938	0.0243	CbGeAlD
Boceprevir—CMA1—digestive system—acquired immunodeficiency syndrome	0.000927	0.024	CbGeAlD
Boceprevir—CTSV—spinal cord—acquired immunodeficiency syndrome	0.000891	0.023	CbGeAlD
Boceprevir—CMA1—blood—acquired immunodeficiency syndrome	0.000883	0.0228	CbGeAlD
Boceprevir—CTSV—vagina—acquired immunodeficiency syndrome	0.000857	0.0222	CbGeAlD
Boceprevir—CMA1—bone marrow—acquired immunodeficiency syndrome	0.000854	0.0221	CbGeAlD
Boceprevir—CTSK—retina—acquired immunodeficiency syndrome	0.000851	0.022	CbGeAlD
Boceprevir—CTSV—lung—acquired immunodeficiency syndrome	0.000811	0.021	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—acquired immunodeficiency syndrome	0.000803	0.0207	CbGeAlD
Boceprevir—CTSL—digestive system—acquired immunodeficiency syndrome	0.000793	0.0205	CbGeAlD
Boceprevir—CMA1—lung—acquired immunodeficiency syndrome	0.000774	0.02	CbGeAlD
Boceprevir—CTSL—blood—acquired immunodeficiency syndrome	0.000755	0.0195	CbGeAlD
Boceprevir—CTSV—nervous system—acquired immunodeficiency syndrome	0.000751	0.0194	CbGeAlD
Boceprevir—CTSK—skin of body—acquired immunodeficiency syndrome	0.000747	0.0193	CbGeAlD
Boceprevir—CTSS—retina—acquired immunodeficiency syndrome	0.000745	0.0193	CbGeAlD
Boceprevir—CTSL—bone marrow—acquired immunodeficiency syndrome	0.000731	0.0189	CbGeAlD
Boceprevir—CTSL—spinal cord—acquired immunodeficiency syndrome	0.000728	0.0188	CbGeAlD
Boceprevir—CTSV—central nervous system—acquired immunodeficiency syndrome	0.000723	0.0187	CbGeAlD
Boceprevir—CTSL—vagina—acquired immunodeficiency syndrome	0.0007	0.0181	CbGeAlD
Boceprevir—CTSL—lung—acquired immunodeficiency syndrome	0.000662	0.0171	CbGeAlD
Boceprevir—CTSS—skin of body—acquired immunodeficiency syndrome	0.000654	0.0169	CbGeAlD
Boceprevir—CTSL—nervous system—acquired immunodeficiency syndrome	0.000613	0.0158	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—acquired immunodeficiency syndrome	0.000605	0.0156	CbGeAlD
Boceprevir—CTSK—digestive system—acquired immunodeficiency syndrome	0.000597	0.0154	CbGeAlD
Boceprevir—CTSL—central nervous system—acquired immunodeficiency syndrome	0.00059	0.0153	CbGeAlD
Boceprevir—CTSV—brain—acquired immunodeficiency syndrome	0.000574	0.0148	CbGeAlD
Boceprevir—CTSK—blood—acquired immunodeficiency syndrome	0.000569	0.0147	CbGeAlD
Boceprevir—CTSK—bone marrow—acquired immunodeficiency syndrome	0.000551	0.0142	CbGeAlD
Boceprevir—CTSK—spinal cord—acquired immunodeficiency syndrome	0.000548	0.0142	CbGeAlD
Boceprevir—CTSS—lymphoid tissue—acquired immunodeficiency syndrome	0.00053	0.0137	CbGeAlD
Boceprevir—CMA1—lymph node—acquired immunodeficiency syndrome	0.000529	0.0137	CbGeAlD
Boceprevir—CTSK—vagina—acquired immunodeficiency syndrome	0.000527	0.0136	CbGeAlD
Boceprevir—CTSS—digestive system—acquired immunodeficiency syndrome	0.000523	0.0135	CbGeAlD
Boceprevir—CTSK—lung—acquired immunodeficiency syndrome	0.000499	0.0129	CbGeAlD
Boceprevir—CTSS—blood—acquired immunodeficiency syndrome	0.000499	0.0129	CbGeAlD
Boceprevir—CTSS—bone marrow—acquired immunodeficiency syndrome	0.000482	0.0125	CbGeAlD
Boceprevir—CTSS—spinal cord—acquired immunodeficiency syndrome	0.00048	0.0124	CbGeAlD
Boceprevir—CTSL—brain—acquired immunodeficiency syndrome	0.000469	0.0121	CbGeAlD
Boceprevir—CTSS—vagina—acquired immunodeficiency syndrome	0.000462	0.0119	CbGeAlD
Boceprevir—CTSK—nervous system—acquired immunodeficiency syndrome	0.000462	0.0119	CbGeAlD
Boceprevir—CTSL—lymph node—acquired immunodeficiency syndrome	0.000453	0.0117	CbGeAlD
Boceprevir—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000452	0.0117	CbGeAlD
Boceprevir—CTSK—central nervous system—acquired immunodeficiency syndrome	0.000445	0.0115	CbGeAlD
Boceprevir—CTSS—lung—acquired immunodeficiency syndrome	0.000437	0.0113	CbGeAlD
Boceprevir—CTSV—Antigen processing-Cross presentation—HLA-B—acquired immunodeficiency syndrome	0.000432	0.0161	CbGpPWpGaD
Boceprevir—CTSL—Antigen processing-Cross presentation—HLA-B—acquired immunodeficiency syndrome	0.000432	0.0161	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000415	0.0155	CbGpPWpGaD
Boceprevir—CTSS—nervous system—acquired immunodeficiency syndrome	0.000405	0.0105	CbGeAlD
Boceprevir—CTSS—central nervous system—acquired immunodeficiency syndrome	0.00039	0.0101	CbGeAlD
Boceprevir—CTSK—brain—acquired immunodeficiency syndrome	0.000353	0.00913	CbGeAlD
Boceprevir—CTSK—lymph node—acquired immunodeficiency syndrome	0.000341	0.00882	CbGeAlD
Boceprevir—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000339	0.00877	CbGeAlD
Boceprevir—CTSS—brain—acquired immunodeficiency syndrome	0.000309	0.008	CbGeAlD
Boceprevir—CTSS—lymph node—acquired immunodeficiency syndrome	0.000299	0.00773	CbGeAlD
Boceprevir—CTSS—Antigen processing-Cross presentation—HLA-B—acquired immunodeficiency syndrome	0.000295	0.011	CbGpPWpGaD
Boceprevir—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00024	0.00621	CbGeAlD
Boceprevir—CTSV—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000204	0.00758	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000204	0.00758	CbGpPWpGaD
Boceprevir—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000174	0.00449	CbGeAlD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—HLA-B—acquired immunodeficiency syndrome	0.000173	0.00642	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—HLA-B—acquired immunodeficiency syndrome	0.000173	0.00642	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000169	0.00628	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000167	0.00623	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000167	0.00623	CbGpPWpGaD
Boceprevir—CYP3A5—blood—acquired immunodeficiency syndrome	0.000166	0.00428	CbGeAlD
Boceprevir—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000153	0.00397	CbGeAlD
Boceprevir—CYP3A5—lung—acquired immunodeficiency syndrome	0.000145	0.00375	CbGeAlD
Boceprevir—CTSS—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000139	0.00517	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000139	0.00516	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000136	0.00505	CbGpPWpGaD
Boceprevir—ABCB1—retina—acquired immunodeficiency syndrome	0.000131	0.0034	CbGeAlD
Boceprevir—CTSL—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000131	0.00488	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000131	0.00488	CbGpPWpGaD
Boceprevir—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00013	0.00337	CbGeAlD
Boceprevir—CYP3A4—blood—acquired immunodeficiency syndrome	0.000124	0.00321	CbGeAlD
Boceprevir—CTSL—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000119	0.00441	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000119	0.00441	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000118	0.0044	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000118	0.0044	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—HLA-B—acquired immunodeficiency syndrome	0.000118	0.00438	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000114	0.00425	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.00011	0.0041	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.00011	0.0041	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000109	0.00404	CbGpPWpGaD
Boceprevir—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000101	0.00261	CbGeAlD
Boceprevir—CTSK—Immune System—ACTG1—acquired immunodeficiency syndrome	9.83e-05	0.00366	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	9.79e-05	0.00364	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MBL2—acquired immunodeficiency syndrome	9.75e-05	0.00363	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MBL2—acquired immunodeficiency syndrome	9.75e-05	0.00363	CbGpPWpGaD
Boceprevir—CYP3A4—central nervous system—acquired immunodeficiency syndrome	9.71e-05	0.00251	CbGeAlD
Boceprevir—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	9.35e-05	0.00242	CbGeAlD
Boceprevir—ABCB1—digestive system—acquired immunodeficiency syndrome	9.23e-05	0.00239	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	9.13e-05	0.0034	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	8.98e-05	0.00334	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	8.98e-05	0.00334	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CCR2—acquired immunodeficiency syndrome	8.95e-05	0.00333	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	8.89e-05	0.00331	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	8.89e-05	0.00331	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	8.88e-05	0.0033	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	8.88e-05	0.0033	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	8.87e-05	0.0033	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	8.87e-05	0.0033	CbGpPWpGaD
Boceprevir—ABCB1—blood—acquired immunodeficiency syndrome	8.8e-05	0.00227	CbGeAlD
Boceprevir—CTSV—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	8.54e-05	0.00318	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	8.54e-05	0.00318	CbGpPWpGaD
Boceprevir—ABCB1—bone marrow—acquired immunodeficiency syndrome	8.51e-05	0.0022	CbGeAlD
Boceprevir—ABCB1—spinal cord—acquired immunodeficiency syndrome	8.47e-05	0.00219	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	8.24e-05	0.00307	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.22e-05	0.00306	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.22e-05	0.00306	CbGpPWpGaD
Boceprevir—ABCB1—vagina—acquired immunodeficiency syndrome	8.15e-05	0.00211	CbGeAlD
Boceprevir—CTSS—Immune System—ACTG1—acquired immunodeficiency syndrome	8.09e-05	0.00301	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MBL2—acquired immunodeficiency syndrome	8.08e-05	0.003	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	8.06e-05	0.003	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	7.86e-05	0.00292	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	7.86e-05	0.00292	CbGpPWpGaD
Boceprevir—ABCB1—lung—acquired immunodeficiency syndrome	7.71e-05	0.00199	CbGeAlD
Boceprevir—CTSL—Immune System—CCR2—acquired immunodeficiency syndrome	7.64e-05	0.00284	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CCR2—acquired immunodeficiency syndrome	7.64e-05	0.00284	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	7.51e-05	0.0028	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	7.44e-05	0.00277	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.44e-05	0.00277	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	7.37e-05	0.00274	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	7.36e-05	0.00274	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	7.35e-05	0.00273	CbGpPWpGaD
Boceprevir—ABCB1—nervous system—acquired immunodeficiency syndrome	7.14e-05	0.00185	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	7.08e-05	0.00263	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNA1—acquired immunodeficiency syndrome	6.88e-05	0.00256	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNA1—acquired immunodeficiency syndrome	6.88e-05	0.00256	CbGpPWpGaD
Boceprevir—ABCB1—central nervous system—acquired immunodeficiency syndrome	6.87e-05	0.00178	CbGeAlD
Boceprevir—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	6.81e-05	0.00253	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD79A—acquired immunodeficiency syndrome	6.68e-05	0.00249	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD79A—acquired immunodeficiency syndrome	6.68e-05	0.00249	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MBL2—acquired immunodeficiency syndrome	6.65e-05	0.00247	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CCR2—acquired immunodeficiency syndrome	6.33e-05	0.00236	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	6.13e-05	0.00228	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	6.07e-05	0.00226	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	6.06e-05	0.00225	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—acquired immunodeficiency syndrome	6.05e-05	0.00225	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	5.83e-05	0.00217	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNA1—acquired immunodeficiency syndrome	5.7e-05	0.00212	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD79A—acquired immunodeficiency syndrome	5.54e-05	0.00206	CbGpPWpGaD
Boceprevir—ABCB1—brain—acquired immunodeficiency syndrome	5.46e-05	0.00141	CbGeAlD
Boceprevir—CTSV—Immune System—CD40LG—acquired immunodeficiency syndrome	5.45e-05	0.00203	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD40LG—acquired immunodeficiency syndrome	5.45e-05	0.00203	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CSF2—acquired immunodeficiency syndrome	5.38e-05	0.002	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CSF2—acquired immunodeficiency syndrome	5.38e-05	0.002	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD8A—acquired immunodeficiency syndrome	5.38e-05	0.002	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—acquired immunodeficiency syndrome	5.38e-05	0.002	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD4—acquired immunodeficiency syndrome	5.31e-05	0.00198	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD4—acquired immunodeficiency syndrome	5.31e-05	0.00198	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—acquired immunodeficiency syndrome	5.27e-05	0.00136	CbGeAlD
Boceprevir—CTSS—Immune System—CCR2—acquired immunodeficiency syndrome	5.21e-05	0.00194	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-B—acquired immunodeficiency syndrome	5.18e-05	0.00193	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-B—acquired immunodeficiency syndrome	5.18e-05	0.00193	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	5.16e-05	0.00192	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	5.16e-05	0.00192	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	5.1e-05	0.0019	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	5.1e-05	0.0019	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.08e-05	0.00189	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	5.02e-05	0.00187	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	4.91e-05	0.00183	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNA1—acquired immunodeficiency syndrome	4.7e-05	0.00175	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.59e-05	0.00171	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD79A—acquired immunodeficiency syndrome	4.56e-05	0.0017	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD40LG—acquired immunodeficiency syndrome	4.51e-05	0.00168	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD8A—acquired immunodeficiency syndrome	4.46e-05	0.00166	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CSF2—acquired immunodeficiency syndrome	4.46e-05	0.00166	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD4—acquired immunodeficiency syndrome	4.4e-05	0.00164	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	4.32e-05	0.00042	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.32e-05	0.00161	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.32e-05	0.00161	CbGpPWpGaD
Boceprevir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	4.31e-05	0.000419	CcSEcCtD
Boceprevir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	4.31e-05	0.000419	CcSEcCtD
Boceprevir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	4.31e-05	0.000419	CcSEcCtD
Boceprevir—Pruritus—Stavudine—acquired immunodeficiency syndrome	4.3e-05	0.000418	CcSEcCtD
Boceprevir—Asthenia—Abacavir—acquired immunodeficiency syndrome	4.3e-05	0.000418	CcSEcCtD
Boceprevir—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	4.29e-05	0.000417	CcSEcCtD
Boceprevir—CTSK—Immune System—HLA-B—acquired immunodeficiency syndrome	4.29e-05	0.0016	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	4.29e-05	0.000417	CcSEcCtD
Boceprevir—Chest pain—Ritonavir—acquired immunodeficiency syndrome	4.28e-05	0.000417	CcSEcCtD
Boceprevir—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	4.28e-05	0.000417	CcSEcCtD
Boceprevir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	4.28e-05	0.000417	CcSEcCtD
Boceprevir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	4.27e-05	0.000415	CcSEcCtD
Boceprevir—Anaemia—Lamivudine—acquired immunodeficiency syndrome	4.27e-05	0.000415	CcSEcCtD
Boceprevir—Anxiety—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000415	CcSEcCtD
Boceprevir—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	4.26e-05	0.000414	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	4.25e-05	0.000414	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	4.24e-05	0.000412	CcSEcCtD
Boceprevir—Pruritus—Abacavir—acquired immunodeficiency syndrome	4.24e-05	0.000412	CcSEcCtD
Boceprevir—Fatigue—Indinavir—acquired immunodeficiency syndrome	4.24e-05	0.000412	CcSEcCtD
Boceprevir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	4.23e-05	0.000412	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	4.23e-05	0.000411	CcSEcCtD
Boceprevir—Cough—Saquinavir—acquired immunodeficiency syndrome	4.23e-05	0.000411	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	4.22e-05	0.00157	CbGpPWpGaD
Boceprevir—Angioedema—Lamivudine—acquired immunodeficiency syndrome	4.22e-05	0.00041	CcSEcCtD
Boceprevir—Pain—Indinavir—acquired immunodeficiency syndrome	4.2e-05	0.000408	CcSEcCtD
Boceprevir—Constipation—Indinavir—acquired immunodeficiency syndrome	4.2e-05	0.000408	CcSEcCtD
Boceprevir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	4.2e-05	0.000408	CcSEcCtD
Boceprevir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	4.2e-05	0.000408	CcSEcCtD
Boceprevir—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	4.19e-05	0.000407	CcSEcCtD
Boceprevir—Hypertension—Saquinavir—acquired immunodeficiency syndrome	4.18e-05	0.000407	CcSEcCtD
Boceprevir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	4.18e-05	0.000406	CcSEcCtD
Boceprevir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	4.18e-05	0.000406	CcSEcCtD
Boceprevir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	4.17e-05	0.000406	CcSEcCtD
Boceprevir—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	4.17e-05	0.000405	CcSEcCtD
Boceprevir—Malaise—Lamivudine—acquired immunodeficiency syndrome	4.17e-05	0.000405	CcSEcCtD
Boceprevir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	4.16e-05	0.000404	CcSEcCtD
Boceprevir—Nausea—Didanosine—acquired immunodeficiency syndrome	4.16e-05	0.000404	CcSEcCtD
Boceprevir—Vertigo—Lamivudine—acquired immunodeficiency syndrome	4.15e-05	0.000404	CcSEcCtD
Boceprevir—Hypotension—Delavirdine—acquired immunodeficiency syndrome	4.15e-05	0.000403	CcSEcCtD
Boceprevir—Syncope—Lamivudine—acquired immunodeficiency syndrome	4.14e-05	0.000403	CcSEcCtD
Boceprevir—Confusional state—Ritonavir—acquired immunodeficiency syndrome	4.14e-05	0.000403	CcSEcCtD
Boceprevir—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	4.14e-05	0.000402	CcSEcCtD
Boceprevir—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	4.14e-05	0.000402	CcSEcCtD
Boceprevir—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	4.12e-05	0.000401	CcSEcCtD
Boceprevir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	4.12e-05	0.000401	CcSEcCtD
Boceprevir—Chest pain—Saquinavir—acquired immunodeficiency syndrome	4.12e-05	0.000401	CcSEcCtD
Boceprevir—Anxiety—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.0004	CcSEcCtD
Boceprevir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	4.1e-05	0.000398	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	4.09e-05	0.000398	CcSEcCtD
Boceprevir—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	4.09e-05	0.000397	CcSEcCtD
Boceprevir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	4.07e-05	0.000396	CcSEcCtD
Boceprevir—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	4.06e-05	0.000395	CcSEcCtD
Boceprevir—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	4.05e-05	0.000394	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	4.05e-05	0.000393	CcSEcCtD
Boceprevir—Shock—Ritonavir—acquired immunodeficiency syndrome	4.04e-05	0.000393	CcSEcCtD
Boceprevir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	4.03e-05	0.000392	CcSEcCtD
Boceprevir—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	4.03e-05	0.000392	CcSEcCtD
Boceprevir—Cough—Lamivudine—acquired immunodeficiency syndrome	4.03e-05	0.000392	CcSEcCtD
Boceprevir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	4.03e-05	0.000392	CcSEcCtD
Boceprevir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	4.03e-05	0.000392	CcSEcCtD
Boceprevir—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	4.02e-05	0.000391	CcSEcCtD
Boceprevir—Dizziness—Stavudine—acquired immunodeficiency syndrome	4.02e-05	0.000391	CcSEcCtD
Boceprevir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	4.02e-05	0.000391	CcSEcCtD
Boceprevir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	4.02e-05	0.000391	CcSEcCtD
Boceprevir—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	4.01e-05	0.00039	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	4.01e-05	0.00039	CcSEcCtD
Boceprevir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	4e-05	0.000389	CcSEcCtD
Boceprevir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	4e-05	0.000389	CcSEcCtD
Boceprevir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.99e-05	0.000388	CcSEcCtD
Boceprevir—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.99e-05	0.000388	CcSEcCtD
Boceprevir—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.99e-05	0.000388	CcSEcCtD
Boceprevir—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.97e-05	0.000386	CcSEcCtD
Boceprevir—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.97e-05	0.000386	CcSEcCtD
Boceprevir—Pain—Efavirenz—acquired immunodeficiency syndrome	3.97e-05	0.000386	CcSEcCtD
Boceprevir—Rash—Nevirapine—acquired immunodeficiency syndrome	3.97e-05	0.000386	CcSEcCtD
Boceprevir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.96e-05	0.000386	CcSEcCtD
Boceprevir—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.96e-05	0.000385	CcSEcCtD
Boceprevir—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.96e-05	0.000385	CcSEcCtD
Boceprevir—Headache—Nevirapine—acquired immunodeficiency syndrome	3.94e-05	0.000383	CcSEcCtD
Boceprevir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.000382	CcSEcCtD
Boceprevir—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.000382	CcSEcCtD
Boceprevir—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.000382	CcSEcCtD
Boceprevir—Infection—Saquinavir—acquired immunodeficiency syndrome	3.93e-05	0.000382	CcSEcCtD
Boceprevir—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.000381	CcSEcCtD
Boceprevir—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.91e-05	0.00038	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.91e-05	0.00038	CcSEcCtD
Boceprevir—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.9e-05	0.000379	CcSEcCtD
Boceprevir—Shock—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000378	CcSEcCtD
Boceprevir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.89e-05	0.000378	CcSEcCtD
Boceprevir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.88e-05	0.000378	CcSEcCtD
Boceprevir—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.88e-05	0.000378	CcSEcCtD
Boceprevir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.88e-05	0.000377	CcSEcCtD
Boceprevir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.88e-05	0.000377	CcSEcCtD
Boceprevir—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.87e-05	0.000376	CcSEcCtD
Boceprevir—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.86e-05	0.000376	CcSEcCtD
Boceprevir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.86e-05	0.000375	CcSEcCtD
Boceprevir—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	3.85e-05	0.000374	CcSEcCtD
Boceprevir—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.84e-05	0.000374	CcSEcCtD
Boceprevir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.84e-05	0.000373	CcSEcCtD
Boceprevir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.84e-05	0.000373	CcSEcCtD
Boceprevir—Hypotension—Ritonavir—acquired immunodeficiency syndrome	3.84e-05	0.000373	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.83e-05	0.000373	CcSEcCtD
Boceprevir—Rash—Stavudine—acquired immunodeficiency syndrome	3.83e-05	0.000373	CcSEcCtD
Boceprevir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.83e-05	0.000372	CcSEcCtD
Boceprevir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.83e-05	0.000372	CcSEcCtD
Boceprevir—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.82e-05	0.000372	CcSEcCtD
Boceprevir—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	3.82e-05	0.000372	CcSEcCtD
Boceprevir—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.82e-05	0.000371	CcSEcCtD
Boceprevir—Headache—Stavudine—acquired immunodeficiency syndrome	3.81e-05	0.00037	CcSEcCtD
Boceprevir—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.81e-05	0.00037	CcSEcCtD
Boceprevir—Confusional state—Lamivudine—acquired immunodeficiency syndrome	3.8e-05	0.00037	CcSEcCtD
Boceprevir—Constipation—Delavirdine—acquired immunodeficiency syndrome	3.8e-05	0.000369	CcSEcCtD
Boceprevir—Pain—Delavirdine—acquired immunodeficiency syndrome	3.8e-05	0.000369	CcSEcCtD
Boceprevir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.8e-05	0.000369	CcSEcCtD
Boceprevir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.79e-05	0.000368	CcSEcCtD
Boceprevir—Rash—Abacavir—acquired immunodeficiency syndrome	3.77e-05	0.000367	CcSEcCtD
Boceprevir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.77e-05	0.000367	CcSEcCtD
Boceprevir—Headache—Abacavir—acquired immunodeficiency syndrome	3.75e-05	0.000365	CcSEcCtD
Boceprevir—Infection—Lamivudine—acquired immunodeficiency syndrome	3.75e-05	0.000364	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.74e-05	0.000364	CcSEcCtD
Boceprevir—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.74e-05	0.000364	CcSEcCtD
Boceprevir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.74e-05	0.000363	CcSEcCtD
Boceprevir—CTSS—Immune System—CD40LG—acquired immunodeficiency syndrome	3.72e-05	0.00138	CbGpPWpGaD
Boceprevir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.71e-05	0.000361	CcSEcCtD
Boceprevir—Shock—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000361	CcSEcCtD
Boceprevir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.7e-05	0.00036	CcSEcCtD
Boceprevir—Hypotension—Saquinavir—acquired immunodeficiency syndrome	3.69e-05	0.000359	CcSEcCtD
Boceprevir—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.69e-05	0.000359	CcSEcCtD
Boceprevir—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.69e-05	0.000359	CcSEcCtD
Boceprevir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	3.69e-05	0.000359	CcSEcCtD
Boceprevir—CTSS—Immune System—CSF2—acquired immunodeficiency syndrome	3.67e-05	0.00137	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD8A—acquired immunodeficiency syndrome	3.67e-05	0.00137	CbGpPWpGaD
Boceprevir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	3.67e-05	0.000357	CcSEcCtD
Boceprevir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.67e-05	0.000357	CcSEcCtD
Boceprevir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.66e-05	0.000356	CcSEcCtD
Boceprevir—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.66e-05	0.000356	CcSEcCtD
Boceprevir—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.66e-05	0.000356	CcSEcCtD
Boceprevir—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	3.65e-05	0.000354	CcSEcCtD
Boceprevir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	3.63e-05	0.000353	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.62e-05	0.00135	CbGpPWpGaD
Boceprevir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.62e-05	0.000352	CcSEcCtD
Boceprevir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	3.62e-05	0.000352	CcSEcCtD
Boceprevir—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	3.61e-05	0.000351	CcSEcCtD
Boceprevir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.61e-05	0.000351	CcSEcCtD
Boceprevir—Nausea—Stavudine—acquired immunodeficiency syndrome	3.61e-05	0.000351	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.6e-05	0.00035	CcSEcCtD
Boceprevir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.57e-05	0.000348	CcSEcCtD
Boceprevir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.57e-05	0.000347	CcSEcCtD
Boceprevir—Nausea—Abacavir—acquired immunodeficiency syndrome	3.56e-05	0.000346	CcSEcCtD
Boceprevir—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.55e-05	0.000345	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.55e-05	0.000345	CcSEcCtD
Boceprevir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.54e-05	0.000344	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-B—acquired immunodeficiency syndrome	3.53e-05	0.00131	CbGpPWpGaD
Boceprevir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	3.53e-05	0.000343	CcSEcCtD
Boceprevir—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.52e-05	0.000343	CcSEcCtD
Boceprevir—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.52e-05	0.000343	CcSEcCtD
Boceprevir—Hypotension—Lamivudine—acquired immunodeficiency syndrome	3.52e-05	0.000343	CcSEcCtD
Boceprevir—Pain—Ritonavir—acquired immunodeficiency syndrome	3.51e-05	0.000341	CcSEcCtD
Boceprevir—Constipation—Ritonavir—acquired immunodeficiency syndrome	3.51e-05	0.000341	CcSEcCtD
Boceprevir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	3.51e-05	0.000341	CcSEcCtD
Boceprevir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.51e-05	0.000341	CcSEcCtD
Boceprevir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	3.49e-05	0.00034	CcSEcCtD
Boceprevir—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	3.48e-05	0.000338	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	3.48e-05	0.00129	CbGpPWpGaD
Boceprevir—Pruritus—Indinavir—acquired immunodeficiency syndrome	3.48e-05	0.000338	CcSEcCtD
Boceprevir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	3.44e-05	0.000334	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	3.44e-05	0.000334	CcSEcCtD
Boceprevir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	3.42e-05	0.000332	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	3.41e-05	0.000332	CcSEcCtD
Boceprevir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	3.41e-05	0.000332	CcSEcCtD
Boceprevir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	3.41e-05	0.000331	CcSEcCtD
Boceprevir—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	3.39e-05	0.000329	CcSEcCtD
Boceprevir—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	3.38e-05	0.000329	CcSEcCtD
Boceprevir—Constipation—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.000329	CcSEcCtD
Boceprevir—Pain—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.000329	CcSEcCtD
Boceprevir—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	3.36e-05	0.000327	CcSEcCtD
Boceprevir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	3.36e-05	0.000327	CcSEcCtD
Boceprevir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	3.36e-05	0.000327	CcSEcCtD
Boceprevir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	3.36e-05	0.000327	CcSEcCtD
Boceprevir—Rash—Zidovudine—acquired immunodeficiency syndrome	3.33e-05	0.000324	CcSEcCtD
Boceprevir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	3.33e-05	0.000324	CcSEcCtD
Boceprevir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	3.33e-05	0.000324	CcSEcCtD
Boceprevir—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	3.32e-05	0.000323	CcSEcCtD
Boceprevir—Headache—Zidovudine—acquired immunodeficiency syndrome	3.31e-05	0.000322	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.29e-05	0.00122	CbGpPWpGaD
Boceprevir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.28e-05	0.000319	CcSEcCtD
Boceprevir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.28e-05	0.000319	CcSEcCtD
Boceprevir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	3.27e-05	0.000318	CcSEcCtD
Boceprevir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	3.26e-05	0.000317	CcSEcCtD
Boceprevir—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	3.26e-05	0.000317	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3.26e-05	0.000317	CcSEcCtD
Boceprevir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	3.25e-05	0.000316	CcSEcCtD
Boceprevir—Dizziness—Indinavir—acquired immunodeficiency syndrome	3.25e-05	0.000316	CcSEcCtD
Boceprevir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	3.25e-05	0.000316	CcSEcCtD
Boceprevir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	3.25e-05	0.000316	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.24e-05	0.0012	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	3.23e-05	0.000314	CcSEcCtD
Boceprevir—Pain—Lamivudine—acquired immunodeficiency syndrome	3.22e-05	0.000314	CcSEcCtD
Boceprevir—Constipation—Lamivudine—acquired immunodeficiency syndrome	3.22e-05	0.000314	CcSEcCtD
Boceprevir—CTSV—Immune System—IFNG—acquired immunodeficiency syndrome	3.2e-05	0.00119	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNG—acquired immunodeficiency syndrome	3.2e-05	0.00119	CbGpPWpGaD
Boceprevir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	3.19e-05	0.00031	CcSEcCtD
Boceprevir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	3.18e-05	0.000309	CcSEcCtD
Boceprevir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	3.14e-05	0.000305	CcSEcCtD
Boceprevir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	3.14e-05	0.000305	CcSEcCtD
Boceprevir—Nausea—Zidovudine—acquired immunodeficiency syndrome	3.14e-05	0.000305	CcSEcCtD
Boceprevir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	3.12e-05	0.000304	CcSEcCtD
Boceprevir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	3.12e-05	0.000304	CcSEcCtD
Boceprevir—Vomiting—Indinavir—acquired immunodeficiency syndrome	3.12e-05	0.000304	CcSEcCtD
Boceprevir—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	3.11e-05	0.000302	CcSEcCtD
Boceprevir—Rash—Indinavir—acquired immunodeficiency syndrome	3.1e-05	0.000301	CcSEcCtD
Boceprevir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	3.09e-05	0.000301	CcSEcCtD
Boceprevir—CTSV—Immune System—CD4—acquired immunodeficiency syndrome	3.09e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—acquired immunodeficiency syndrome	3.09e-05	0.00115	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	3.08e-05	0.0003	CcSEcCtD
Boceprevir—Headache—Indinavir—acquired immunodeficiency syndrome	3.08e-05	0.000299	CcSEcCtD
Boceprevir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	3.07e-05	0.000298	CcSEcCtD
Boceprevir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	3.04e-05	0.000295	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.03e-05	0.00113	CbGpPWpGaD
Boceprevir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	3.03e-05	0.000294	CcSEcCtD
Boceprevir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	3e-05	0.000291	CcSEcCtD
Boceprevir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.98e-05	0.00029	CcSEcCtD
Boceprevir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.98e-05	0.00029	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.96e-05	0.0011	CbGpPWpGaD
Boceprevir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.95e-05	0.000287	CcSEcCtD
Boceprevir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.95e-05	0.000286	CcSEcCtD
Boceprevir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.94e-05	0.000286	CcSEcCtD
Boceprevir—Rash—Efavirenz—acquired immunodeficiency syndrome	2.93e-05	0.000285	CcSEcCtD
Boceprevir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.92e-05	0.000284	CcSEcCtD
Boceprevir—Nausea—Indinavir—acquired immunodeficiency syndrome	2.92e-05	0.000284	CcSEcCtD
Boceprevir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.91e-05	0.000283	CcSEcCtD
Boceprevir—Headache—Efavirenz—acquired immunodeficiency syndrome	2.91e-05	0.000283	CcSEcCtD
Boceprevir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.91e-05	0.000283	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.87e-05	0.00107	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.87e-05	0.00107	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—acquired immunodeficiency syndrome	2.85e-05	0.00106	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—acquired immunodeficiency syndrome	2.85e-05	0.00106	CbGpPWpGaD
Boceprevir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.84e-05	0.000276	CcSEcCtD
Boceprevir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.82e-05	0.000275	CcSEcCtD
Boceprevir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.81e-05	0.000273	CcSEcCtD
Boceprevir—Rash—Delavirdine—acquired immunodeficiency syndrome	2.8e-05	0.000272	CcSEcCtD
Boceprevir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.8e-05	0.000272	CcSEcCtD
Boceprevir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.8e-05	0.000272	CcSEcCtD
Boceprevir—Headache—Delavirdine—acquired immunodeficiency syndrome	2.78e-05	0.000271	CcSEcCtD
Boceprevir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.78e-05	0.00027	CcSEcCtD
Boceprevir—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.76e-05	0.000268	CcSEcCtD
Boceprevir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.72e-05	0.000264	CcSEcCtD
Boceprevir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.71e-05	0.000263	CcSEcCtD
Boceprevir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.7e-05	0.000263	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.7e-05	0.001	CbGpPWpGaD
Boceprevir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.67e-05	0.000259	CcSEcCtD
Boceprevir—CTSK—Immune System—IFNG—acquired immunodeficiency syndrome	2.65e-05	0.000987	CbGpPWpGaD
Boceprevir—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.64e-05	0.000256	CcSEcCtD
Boceprevir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.61e-05	0.000254	CcSEcCtD
Boceprevir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.61e-05	0.000254	CcSEcCtD
Boceprevir—Rash—Ritonavir—acquired immunodeficiency syndrome	2.59e-05	0.000252	CcSEcCtD
Boceprevir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.59e-05	0.000252	CcSEcCtD
Boceprevir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.58e-05	0.000251	CcSEcCtD
Boceprevir—Headache—Ritonavir—acquired immunodeficiency syndrome	2.57e-05	0.00025	CcSEcCtD
Boceprevir—CTSK—Immune System—CD4—acquired immunodeficiency syndrome	2.56e-05	0.000953	CbGpPWpGaD
Boceprevir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.51e-05	0.000244	CcSEcCtD
Boceprevir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.49e-05	0.000242	CcSEcCtD
Boceprevir—Rash—Saquinavir—acquired immunodeficiency syndrome	2.49e-05	0.000242	CcSEcCtD
Boceprevir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.49e-05	0.000242	CcSEcCtD
Boceprevir—Headache—Saquinavir—acquired immunodeficiency syndrome	2.48e-05	0.000241	CcSEcCtD
Boceprevir—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.44e-05	0.000237	CcSEcCtD
Boceprevir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.4e-05	0.000233	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—IL6—acquired immunodeficiency syndrome	2.38e-05	0.000885	CbGpPWpGaD
Boceprevir—Rash—Lamivudine—acquired immunodeficiency syndrome	2.38e-05	0.000231	CcSEcCtD
Boceprevir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.38e-05	0.000231	CcSEcCtD
Boceprevir—Headache—Lamivudine—acquired immunodeficiency syndrome	2.36e-05	0.00023	CcSEcCtD
Boceprevir—CTSK—Immune System—IL2—acquired immunodeficiency syndrome	2.36e-05	0.000877	CbGpPWpGaD
Boceprevir—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.35e-05	0.000228	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	2.32e-05	0.000863	CbGpPWpGaD
Boceprevir—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.000218	CcSEcCtD
Boceprevir—CTSS—Immune System—IFNG—acquired immunodeficiency syndrome	2.18e-05	0.000813	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—acquired immunodeficiency syndrome	2.11e-05	0.000785	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	1.97e-05	0.000734	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.96e-05	0.000731	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.96e-05	0.000729	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000722	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.75e-05	0.000651	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.71e-05	0.000636	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—acquired immunodeficiency syndrome	1.67e-05	0.000622	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—acquired immunodeficiency syndrome	1.67e-05	0.000622	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.49e-05	0.000554	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—acquired immunodeficiency syndrome	1.39e-05	0.000516	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000425	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.08e-05	0.000401	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.01e-05	0.000374	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.69e-06	0.000361	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	9.17e-06	0.000341	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.52e-06	0.000242	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	4.04e-06	0.00015	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.05e-06	0.000114	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.88e-06	6.99e-05	CbGpPWpGaD
